Medical Health & Life Science Research News

Drug discovery informatics market worth 2.84 billion USD by 2022

Drug discovery informatics market worth 2.84 billion USD by 2022

The global drug discovery informatics market is expected to reach USD 2.84 Billion from USD 1.67 Billion at a CAGR of 11.2%. Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions.

- Advertising -

Browse 63 market data Tables and 24 Figures spread through 115 Pages and in-depth TOC on "Drug Discovery Informatics Market"

www.marketsandmarkets.com/Market-R…ket-64537381.html

Based on function, the sequencing and target data analysis segment is accounted for the largest share of the market in 2017 

On the basis of function, the Drug Discovery Informatics Market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the Drug Discovery Informatics Market.

Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

Access report @ www.marketsandmarkets.com/pdfdownl…mpaign=prnewswire

Based on solution, the software segment is accounted for the largest share of the market in 2017 

The solution segment of the Drug Discovery Informatics Market is divided into software and services.

- Advertising -

In 2017, the software segment is expected to account for the largest share of the global Drug Discovery Informatics Market. The dominant share of this market is attributed to the fact that drug discovery informatics software solutions enable the fast and efficient management of data generated throughout the drug discovery process.

North America is expected to dominate the market in 2017 

The North America is expected to account for the largest share of the Drug Discovery Informatics Market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology company's attributes to the largest share of North America.

Europe is expected to account for the second-largest share of the Drug Discovery Informatics Market.

Speak To Analyst: www.marketsandmarkets.com/speaktoa…mpaign=prnewswire

The key players operating in the Drug Discovery Informatics Market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...